Source(s) of activator calcium for noradrenaline-induced vasoconstriction in the perfused rabbit isolated ovarian vascular bed - A role for tyrosine kinase
Mh. Yousif et al., Source(s) of activator calcium for noradrenaline-induced vasoconstriction in the perfused rabbit isolated ovarian vascular bed - A role for tyrosine kinase, GEN PHARM, 32(5), 1999, pp. 563-570
The effects of Ca2+ withdrawal and agents affecting Ca2+ translocation on a
lpha(1)-adrenoceptor-mediated vasoconstrictor responses in the perfused rab
bit ovarian vascular bed were studied. Noradrenaline-induced vasoconstricti
on was lost in a Ca2+-free Krebs' solution, and the rate of loss of the res
ponse was accelerated by EGTA (2 mM). Noradrenaline-induced vasoconstrictio
n and SDZ NVI085-induced vasoconstriction were concentration-dependently in
hibited by verapamil and nifedipine. These agents were, however, more effec
tive against KCl-induced responses. Cyclopiazonic acid, an intracellular Ca
2+ depletor, concentration-dependently inhibited noradrenaline-induced resp
onses and abolished the response in Ca2+-free Krebs' solution. GF 109203X a
nd polymyxin B, inhibitors of protein kinase C (PKC), had no significant ef
fect on noradrenaline-induced responses. Tyrosine kinase inhibitors, genist
ein and erbstatin, inhibited noradrenaline-induced vasoconstriction in the
perfused rabbit ovarian vascular bed. The results would suggest that both e
xtracellular Ca2+ and intracellular Ca2+ participate in noradrenaline-induc
ed vasoconstrictor responses in the perfused rabbit ovarian vascular bed. T
he results would also suggest that tyrosine kinase and not protein kinase C
activation has a role in such effects. (C) 1999 Elsevier Science Inc. All
rights reserved.